logo

Last Update

This profile was last updated on 8/9/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Glenn Crocker?

Glenn Crocker

Chief Executive Officer

BioCity companies

HQ Phone:  +44 115 912 4210

Direct Phone: +44 *** *** ****direct phone

Email: g***@***.uk

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

BioCity companies

Pennyfoot Street

Nottingham, Nottinghamshire,NG1 1GF

United Kingdom

Company Description

BioCity Nottingham Ltd has developed and operates one of the largest bioscience incubators in Europe. Home to around 70 early-stage businesses it is a hot-bed of entrepreneurial activity in the sector. As well as providing very flexible laboratory and office f...more

Web References(170 Total References)


Our story - BioCity

www.biocity.co.uk [cached]

Dr. Glenn Crocker became BioCity's first CEO in 2003, and within two years the site was hosting 20 early-stage companies.


CQ Board - Creative Quarter

www.creativequarter.com [cached]

Glenn Crocker, Board Member
Glenn Crocker Glenn has been CEO of BioCity since mid-2003, joining the business shortly after it was founded. He has a DPhil in Immunology from Oxford University and qualified as a chartered accountant with Ernst & Young. At BioCity, Glenn has grown a thriving life science incubation business on the back of a strong commitment to building successful life science companies. BioCity now creates and develops life science start-ups, invests in the companies it knows well and provides them with the ideal environment for success at one of four sites across the UK. Glenn led the expansion of BioCity from its Nottingham city centre base into facilities in Scotland, Manchester and the Boots campus. In 2014, Glenn was awarded an MBE for services to the biotechnology industry. He also founded the Mobius Life Sciences Fund, R5 Pharmaceuticals in Nottingham, subsequently sold to Aesica, and BioAscent in Scotland and is a non-executive Director of a number of other life science businesses including Xenogesis and BioImages Group. Glenn Crocker


The Management Team - Alderley Analytical

alderleyanalytical.com [cached]

Glenn Crocker, chief executive of BioCity
Glenn Crocker MBE Board Member Glenn has a BSc in Genetics from Nottingham University and a DPhil in Immunology from Oxford University. Following a short time in post-doctoral research he joined Ernst & Young and qualified as a chartered accountant. During his 12 years at BioCity Nottingham he has grown this ex Boots R&D City Centre site into a profitable business through his innovative approach to business incubation where the focus is on the company and its ability to survive and grow profitably. This approach attracted 96 companies to start life with BioCity and 91% of those companies remain in business and continue to grow. Glenn was the co-founder of R5 Pharmaceuticals (which was subsequently sold to Aesica) and BioAscent Discovery and has been closely involved in the establishment of Xenogesis and a number of other life science companies. He has led the expansion of BioCity into Scotland; established collaborations with Boots, a member of Alliance Boots, to create MediCity - the health, beauty and wellness innovation hub; and was appointed by Astra Zeneca to create a BioHub at its Alderley Park site, Cheshire. BioCity and Glenn have received a number of awards in recognition of these achievements. He is the author of the UK Life Sciences Start-up Report, an annual survey of the UK start up sector and co-founder of the UK Bio-incubation Forum - a leading membership association and independent voice for life science business incubation and accelerated growth, influencing policy at local, national, European and international level. In June 2014 Glenn was awarded an MBE for services to the Biotechnology Industry.


Gillian Hunter | LATi | Page 2

lati.org.uk [cached]

Alasdair Gaw of Innovate UK, Glenn Crocker, CEO of BioCity Nottingham, Stefan Ogrodzinski CEO of BioStatus and Kirsty Gapp of 3M shared their experiences of what makes a [...]


Upcoming Events | LATi 2016 BioScience Showcase | LATi

lati.org.uk [cached]

Dr Glenn Crocker
Glenn Crocker is to talk about the foundations to becoming a profitable start-up in this sector, covering company creation, investment and early growth, including data in the 2015 life sciences start up report. Dr Glenn Crocker, became CEO of BioCity Nottingham in 2003, growing it to be one of the largest bioscience incubators in Europe. Glenn was a founder of R5 Pharmaceuticals, which was subsequently sold to Aesica, and he is a non-executive director of a number of other companies including Mobius Life Sciences, Xenogesis and Medilink East Midlands. Dr Glenn Crocker was awarded an MBE in the Queen's birthday honours list in 2014 for services to the Biotechnology Industry.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory